Seminars in Radiation Oncology
Volume 16, Issue 4 , Pages 224-231, October 2006

The Clinical Application of Intensity-Modulated Radiation Therapy

  • Randall K. Ten Haken, PhD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Randall K. Ten Haken, PhD, University of Michigan, Department of Radiation Oncology, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-0010.
  • ,
  • Theodore S. Lawrence, MD, PhD

Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, MI.

Intensity-modulated radiation therapy is a delivery system that, when coupled with a treatment-planning optimization system, presents the opportunity to conform the dose to the target better than 3-dimensional conformal therapy, particularly in the case of concave targets. Appropriate clinical applications of this technology to challenging patient treatment scenarios requires careful consideration of issues related to target volume-dose heterogeneity and the influence of patient setup uncertainties. These issues are reviewed and illustrated. To date, clinical reports of these treatments for prostate and head and neck cancers have the most mature data. Those results are summarized here. Future applications of this technology can be expected to take careful, considered advantage of this technology to further rearrange dose distributions across target volumes to produce an integrated overall gain in treatment objectives. However, these innovative applications need to be approached with caution, preferably in prospective clinical trials that would help determine if the hypothetical clinical benefits are in fact realizable.

Keywords:  IMRT , radiotherapy treatment planning optimization

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by NIH Grant P01CA59872.

PII: S1053-4296(06)00031-2

doi:10.1016/j.semradonc.2006.04.005

Seminars in Radiation Oncology
Volume 16, Issue 4 , Pages 224-231, October 2006